GRN and Alzheimer disease: A recent study used granulin-domain antibodies to identify immunoreactive structures in AD brains similar to what we have characterized [35]; however the granulin sub-domain antibodies used would have the ability to also detect PGRN, so the issue of the amount of PGRN compared to granulin in plaque structures will require further investigation.